Additional Proxy Soliciting Materials (definitive) (defa14a)
July 14 2020 - 5:16PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE
14A
Proxy Statement Pursuant to Section
14(a) of
the Securities Exchange Act of 1934
Filed by the Registrant x
Filed by a party other than the Registrant ¨
Check the appropriate box:
|
¨
|
Preliminary Proxy Statement
|
|
¨
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
¨
|
Definitive Proxy Statement
|
|
x
|
Definitive Additional Materials
|
|
¨
|
Soliciting Material Under §240.14a-12
|
MENLO
THERAPEUTICS INC.
(Name of Registrant as Specified In Its
Charter)
(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
¨
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on
which the filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
|
¨
|
Fee paid previously with preliminary materials.
|
|
¨
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and
the date of its filing.
|
|
(1)
|
Amount previously paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing party:
|
|
|
|
|
(4)
|
Date Filed:
|
|
|
|
YOUR VOTE IS IMPORTANT
PLEASE VOTE YOUR PROXY TODAY July 14, 2020 Dear Stockholders, According to our latest records, we have not received your voting
instructions for the Annual Meeting of Stockholders of Menlo Therapeutics Inc., to be held on August 3, 2020. Your vote is extremely
important, no matter how many shares you hold. For the reasons set forth in the proxy statement, the Board of Directors unanimously
recommends that you vote FOR the election of the director nominees, FOR the ratification of the appointment of PricewaterhouseCoopers
LLP as the independent registered public accounting firm, and FOR the approval and adoption of the Reverse Stock Split Amendment,
as described in Proposals 1-3 of the Proxy Statement. If you need assistance voting your shares, please call D.F. King & Co.,
Inc. toll free at (800) 848-2998. On behalf of your Board of Directors, thank you for your cooperation and continued support.
Sincerely, David Domzalski President and Chief Executive Officer THREE EASY WAYS TO VOTE Please call the toll-free number
listed on your voting instruction form and follow the instructions provided. 1-800-454-8683 Please access the website listed on
your voting instruction form and follow the instructions provided. www.proxyvote.com Please mark, sign, date and promptly return
the voting instruction form in the postage-paid envelope provided.
Menlo Therapeutics (NASDAQ:MNLO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Menlo Therapeutics (NASDAQ:MNLO)
Historical Stock Chart
From Sep 2023 to Sep 2024